July 06, 2022
2 min watch
Save
VIDEO: Tyrvaya increases Schirmer’s score in patients with dry eye
CHICAGO – Tyrvaya nasal spray was shown to increase Schirmer’s scores in 4 weeks in the ONSET-1 and ONSET-2 clinical trials, Leslie O’Dell, OD, said at Optometry’s Meeting.
Patients using OC-01, or Tyrvaya (varenicline solution 0.03 mg, Oyster Point Pharma) increased by 5.5 mm, whether or not they started off with mild or severe dry eye, she said.
Published by:
Sources/Disclosures
Collapse
Source:
O’Dell L, et al. Effect of OC-01 (varenicline solution) nasal spray compared to vehicle control on dry eye disease sign outcomes by baseline subgroup characteristics.
Disclosures:
O’Dell reports being an advisory board member for Oyster Point Pharma.
Read more about